Mpo inhibitors for use in medicine
AssigneeAstraZeneca AB
InventorsAndrew WHITTAKER, Hitesh Jayantilal SANGANEE
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to new therapeutic uses of MPO inhibitors and methods of treatment involving the same.
Claims12
1-14. (canceled)
A method of treatment or prophylaxis of male infertility in a patient in need thereof, comprising administering to said patient a therapeutically effective amount of a myeloperoxidase (MPO) inhibitor.
A kit comprising a pharmaceutical composition comprising a MPO inhibitor or a pharmaceutically acceptable salt or solvate thereof, and instructions to administer the pharmaceutical composition in a method of treatment or prophylaxis of male idiopathic infertility.
Dependencies are inferred from the claim text.